These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2977903)

  • 1. Terguride in the treatment of prolactin-induced luteal insufficiency.
    Vĕtr M; Talas M
    Acta Univ Palacki Olomuc Fac Med; 1988; 120():289-94. PubMed ID: 2977903
    [No Abstract]   [Full Text] [Related]  

  • 2. [Terguride in the treatment of hyperprolactinemia and acromegaly].
    Marek J; Bauer J; Srámková J; Hána V
    Cas Lek Cesk; 1986 Jan; 125(4):100-5. PubMed ID: 3948223
    [No Abstract]   [Full Text] [Related]  

  • 3. [Follow-up of the effect of prolactin-lowering substances].
    Gazárek F; Talas M; Stehlíková J; Zenísek L; Fingerová H
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():102-9. PubMed ID: 6242680
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lisuride in the treatment of sterility and amenorrhoea induced by elevated prolactin levels (author's transl)].
    Marek J; Zivný J; Srámková J; Kobilková J
    Cesk Gynekol; 1981 Sep; 46(8):593-600. PubMed ID: 7307108
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lisurid in the treatment of hyperprolactinemia: comments on the article by J. Presl].
    Pospísil O
    Cesk Gynekol; 1980 Nov; 45(9):679-81. PubMed ID: 7197199
    [No Abstract]   [Full Text] [Related]  

  • 6. [Significance and therapy of luteal insufficiency].
    Birkhäuser MH; Werner-Zodrow I
    Ther Umsch; 1985 Jul; 42(7):435-40. PubMed ID: 4049301
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic treatment of pathological hyperprolactinemia and acromegaly with the new ergot derivative terguride.
    Dallabonzana D; Liuzzi A; Oppizzi G; Cozzi R; Verde G; Chiodini P; Rainer E; Dorow R; Horowski R
    J Clin Endocrinol Metab; 1986 Oct; 63(4):1002-7. PubMed ID: 3745401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of terguride on prolactin levels in normal, puerperal and hyperprolactinaemic women.
    Venturini PL; Horowski R; Valenzano M; Costantini S; Fasce V; Gorlero F; Rainer E; De Cecco L
    Eur J Clin Pharmacol; 1986; 30(2):195-7. PubMed ID: 3709645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteal phase inadequacy. Its significance in infertility.
    Murthy YS; Arronet GH; Parekh MC
    Obstet Gynecol; 1970 Nov; 36(5):758-61. PubMed ID: 5474006
    [No Abstract]   [Full Text] [Related]  

  • 10. [A new synthetic progesterone in luteal insufficiency].
    Lanvin M; Pouplet G; Trévoux R
    Rev Fr Gynecol Obstet; 1976 Oct; 71(10):595-8. PubMed ID: 1033602
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of lisuride in the treatment of anovulatory disorders with prolactinemia].
    Uzel R; Závada M; Safarcík K
    Cesk Gynekol; 1984 Apr; 49(3):186-90. PubMed ID: 6722915
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of the new ergot derivative terguride on plasma PRL and GH levels in patients with pathological hyperprolactinemia or acromegaly.
    Dallabonzana D; Liuzzi A; Oppizzi G; Verde G; Chiodini PG; Dorow R; Horowski R
    J Endocrinol Invest; 1985 Apr; 8(2):147-51. PubMed ID: 4031381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteal phase defects.
    Andrews WC
    Fertil Steril; 1979 Nov; 32(5):501-9. PubMed ID: 387452
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolactin and luteal insufficiency.
    Schneider HP; Goeser R; Cirkel U
    Rev Med Brux; 1982 Nov; 3(9):611-8. PubMed ID: 7163703
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lisuride in the treatment of hyperprolactinemia].
    Presl J
    Cesk Gynekol; 1980 Apr; 45(3):189-91. PubMed ID: 7379162
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hyperprolactinemia syndrome in men].
    Balabolkin MI; Gerasimov GA; Gorokhova TR; Liubimov AV
    Sov Med; 1990; (4):23-6. PubMed ID: 2374967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromocryptine therapy in luteal insufficiency.
    Godó G; Sas M; Falkay G
    Acta Med Acad Sci Hung; 1980; 37(3):283-8. PubMed ID: 7192924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current theories on corpus luteum insufficiency].
    Rozmus M
    Postepy Hig Med Dosw; 1980; 34(3):235-47. PubMed ID: 6791145
    [No Abstract]   [Full Text] [Related]  

  • 19. Terguride in the treatment of hyperprolactinemia.
    Vĕtr M; Talas M; Pohanka J; Gazárek F; Fingerová H
    Acta Univ Palacki Olomuc Fac Med; 1990; 125():155-60. PubMed ID: 2150271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of dironyl in the treatment of acromegaly and hyperprolactinemia].
    Felt V; Nedvídková J
    Vnitr Lek; 1985 Oct; 31(10):980-5. PubMed ID: 4090298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.